AB0175 INNOVATIVE PREPARATION OF CURCUMIN NANOPARTICLES TO IMPROVE ANTI-INFLAMMATORY EFFECT IN RHEUMATIC DISEASE

Background: Curcumin (Cur) as a natural compound can be used in the wide spectrum of healthy functions and pharmacological activities [1-4]. It shows great promise for medication of various pro-inflammatory chronic illnesses [5]. In this study, we evaluate the ability of poly(lactide-co-glycolide)(PLGA) and different grads of PVA (polyvinyl alcohol) and lecithin as a drug delivery system for poorly soluble Cur Objectives: The goal of this study was to prepare and characterize Cur encapsulated PLGA and different grads of PVA and lecithin as an efficient nanocarrier for improve anti-inflammatory effect in rheumatic disease Methods: The PLGA nanospheres were formulated and then characterized for percent yield, encapsulation efficiency, surface morphology, and in vitro drug release profiles. At first, 6 mg of Cur was added to the organic phase including 24 mg of polymer dissolved in 5 mL of dichloromethane to constitute 1:4 (drug-to-polymer) ratios. Then, a mixture of PVA-lecithin (at about 5 cc) was added to maintain the stability of double emulsion droplets. The emulsion was continuously stirred at 300 rpm for 24 hours (at temperature of 37.5 ˚C) to evaporate the solvent, leaving behind the colloidal suspension of the drug-encapsulated nanoparticle in aqueous phase. The encapsulation of Cur into PLGA was characterized by Fourier transform infrared spectroscopy (FT-IR) and Transmission electron microscopy (TEM). Results: Our studies achieved the successful formation of smooth surface and spherical shape Cur encapsulated into PLGA nanoparticles by the TEM image confirmed. The particle size distribution demonstrated a range of 30 nm to 100 nm, with the mean particle size being 45 nm. FTIR study implies successful loading of Cur into the nanoparticles. We show high drug-loading efficiency about 98 ± 0.5% for 6% of Cur weight in total ingredients weight of PLGA (w/w). It was also seen that a slower sustained release of 10% CUR in 48 hours is observed with biocompatible PLGA in phosphate buffered saline (pH = 7.4). The MTT assay of the Cur-PLGA exhibited no cytotoxic effect on Normal mouse fibroblast cells (L-929) cell line. IC50 of Cur -PLGA increased 99.5% against Cur nanoparticles (33.57 ±0.62 µM) (P < 0.05). Conclusion: In this study, we constructed a novel preparation of curcumin nanoparticles with PLGA and different grads of PVA (polyvinyl alcohol) and lecithin to improve the bioavailability of CUR and PLGA exhibited no cytotoxic effect on L-929 cell line References: In this study, we constructed a novel preparation of curcumin nanoparticles with PLGA and different grads of PVA (polyvinyl alcohol) and lecithin to improve the bioavailability of CUR and PLGA exhibited no cytotoxic effect on L-929 cell line Disclosure of Interests: None declared